首页|活血化瘀类中药饮片与口服抗凝血药联合应用的出血风险研究

活血化瘀类中药饮片与口服抗凝血药联合应用的出血风险研究

扫码查看
目的:探讨联合应用活血化瘀类中药饮片与口服抗凝血药治疗疾病的出血风险。方法:回顾性研究 2022 年该院服用口服抗凝血药和活血化瘀类中药饮片的住院患者 158 例,根据是否联合应用活血化瘀类中药饮片分为联合组(80 例)和对照组(78 例)。对照组患者使用的口服抗凝血药包括华法林、利伐沙班、达比加群酯;联合组患者联合应用的活血化瘀类中药饮片包括丹参、川芎、牛膝等。观察两组患者的凝血功能相关指标如凝血酶原时间-国际标准化比值(PT-INR)、纤维蛋白原(FIB)、D-二聚体(D-D)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)和出血事件发生率等。结果:联合组与对照组患者 PT-INR、FIB、D-D、APTT和TT的差异均无统计学意义(P>0。05);联合组患者的出血事件发生率为 66。25%(53/80),高于对照组的 42。31%(33/78),差异有统计学意义(P<0。05)。结论:患者联合应用活血化瘀类中药饮片与口服抗凝血药后,虽然相关凝血指标并未出现明显变化,但是出血事件发生率显著升高。临床用药时,需重点关注含有丹参、川芎、牛膝和红花等的活血化瘀类中药饮片或中药复方制剂与口服抗凝血药联合应用会增加出血的风险。本研究为中西药相互作用研究提供了一定的借鉴。
Bleeding Risk Evaluation of Chinese Medicine Decoctions for Promoting Blood Circulation and Removing Blood Stasis Combined with Oral Anticoagulants
OBJECTIVE:To explore the bleeding risk of Chinese medicine decoctions for promoting blood circulation and removing blood stasis combined with oral anticoagulants.METHODS:A total of 158 patients who received oral anticoagulants and Chinese medicine decoctions for promoting blood circulation and removing blood stasis in the hospital in 2022 were extracted to be divided into the combined group(n=80)and control group(n=78)according to different treatment regimen of Chinese medicine decoctions for promoting blood circulation and removing blood stasis.The oral anticoagulants in the control group included warfarin,rivaroxaban,and dabigatran etexilate;while the Chinese medicine decoctions for promoting blood circulation and removing blood stasis used in the combined group included Radix Salviae,Chuanxiong Rhizoma,Achyranthis Bidentatae Radix,etc..Prothrombin time-international normalized ratio(PT-INR),fibrinogen(FIB),D-dimer(D-D),activated partial thromboplastin time(APTT),thrombin time(TT)and incidence of bleeding events of two groups were observed.RESULTS:There were no significant differences in PT-INR,FIB,D-D,APTT and TT between the combined group and control group(P>0.05).The incidence of bleeding events in the combined treatment group was 66.25%(53/80),higher than 42.31%(33/78)in the control group,the difference was statistically significant(P<0.05).CONCLUSIONS:Although the relevant coagulation indicators do not change significantly after the combined use of Chinese medicine decoctions for promoting blood circulation and removing blood stasis and oral anticoagulants,the incidence of bleeding events in patients increased significantly.In clinical use,it is necessary to pay attention to Chinese medicine decoctions for promoting blood circulation and removing blood stasis,including Radix Salviae,Chuanxiong Rhizoma,Achyranthis Bidentatae Radix and Carthami Flos,or the combination of Chinese medicine decoctions and oral anticoagulants could increase the risk of bleeding.This study provides some reference for the study of interaction between Chinese and Western medicines.

Chinese medicine decoctions for promoting blood circulation and removing blood stasisOral anticoagulantsBleeding riskChinese combined with Western medicines

杜秋、丁淜、郭华

展开 >

南京中医药大学附属南京中医院药学部,南京 210022

中国药科大学基础医学与临床药学学院,南京 210000

南京中医药大学附属南京中医院信访行风办,南京 210022

活血化瘀类中药饮片 口服抗凝血药 出血风险 中西药联合应用

江苏省自然科学基金青年基金南京市卫生科技发展专项南京市中医药卫生青年人才项目

BK20210035YKK20166ZYQ20012

2024

中国医院用药评价与分析
中国医药生物技术协会,中国药房杂志社

中国医院用药评价与分析

CSTPCD
影响因子:1.142
ISSN:1672-2124
年,卷(期):2024.24(3)
  • 22